# US 2024/0390668 A1 · Cured ring seal

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0390668 A1
- Document ID: US20240390668A1
- Status: Published application
- Kind: A1
- Application number: 18/686,108
- Filed: 2022-08-12
- Published: 2024-11-28
- Earliest claimed: 2021-09-01
- Assignees: Cochlear Limited
- Applicants: Cochlear Limited
- Inventors: Jonathon KIRK
- Web page: https://patentgrep.com/patent/US20240390668A1

## CPC

- A61N 1/0541: {Cochlear electrodes}
- A61N 1/36038: {Cochlear stimulation}
- A61M 31/00: Devices for introducing or retaining media, e.g. remedies, in cavities of the body (A61M25/00 takes precedence {; introducing or retaining ophthalmic products into the ocular cavities A61F9/0008})
- F16J 15/102: {characterised by material}
- A61F 11/00: Methods or devices for treatment of the ears or hearing sense (implantable prostheses that substitute or replace internal ear parts, e.g. ear-drums, A61F2/18; methods or devices to cause a change in the state of auditory consciousness A61M21/00; electrotherapy applying electrical stimulation of the auditory system, or circuits therefor A61N1/36; radiotherapy using optical stimulation of the auditory system A61N5/06; electro-acoustic hearing aids H04R25/00); Non-electric hearing aids; Methods or devices for enabling ear patients to achieve auditory perception through physiological senses other than hearing sense; Protective devices for the ears, carried on the body or in the hand (headwear, e.g. caps or helmets, with means for protecting the ears A42B1/0188, A42B3/16)
- A61F 2250/0067: Means for introducing or releasing pharmaceutical products into the body
- A61M 2210/0662: Ears
- A61N 1/375: Constructional arrangements, e.g. casings
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- F16J: PISTONS {(specially adapted for dampers F16F9/32)}; CYLINDERS; SEALINGS
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

Presented herein are cured ring seals and related methods for at least temporarily sealing openings in fluidically-sealed body chambers. The cured ring seals include a body that is formed from a hydrophilic or hygroscopic polymer, such as polyvinyl alcohol (PVA), that is cured prior to implantation into the body of a recipient (e.g., pre-cured). The cured ring seals are substantially pliable to facilitate positioning around an outer surface of an implantable component and are configured to expand following implantation.

## Claims

### Claim at position 1

1-14. (canceled)

### Claim 15

A method, comprising:
accessing an opening to a fluidically-sealed body chamber in a body of a recipient;
positioning a cured ring seal adjacent to tissue surrounding the opening, wherein the cured ring seal includes an aperture extending there through; and
inserting an implantable component into the fluidically-sealed body chamber via the opening, wherein the implantable component extends though the aperture in the cured ring seal,
wherein the cured ring seal fluidically-seals the opening around the implantable component.

### Claim 16 (depends on 15)

The method of claim 15, further comprising:
positioning the cured ring seal adjacent the tissue surrounding the opening before implantation of the implantable component,
wherein the implantable component is inserted into the opening via the aperture in the cured ring seal.

### Claim 17 (depends on 15)

The method of claim 15, further comprising:
positioning the cured ring seal around an outer surface of the implantable component before insertion of the implantable component into the fluidically-sealed body chamber.

### Claim 18 (depends on 17)

The method of claim 17, further comprising:
inserting the implantable component into the fluidically-sealed body chamber until the cured ring seal is adjacent the tissue surrounding the opening.

### Claim 19 (depends on 18)

The method of claim 18, further comprising:
determining an insertion depth for the implantable component in the fluidically-sealed body chamber; and
positioning the cured ring seal at a location on the implantable component that is determined based on the insertion depth for the implantable component.

### Claim 20 (depends on 15)

The method of claim 15, wherein positioning the cured ring seal adjacent tissue surrounding the opening comprises:
positioning the cured ring seal adjacent a proximal surface of the tissue surrounding the opening.

### Claim 21 (depends on 15)

The method of claim 15, wherein positioning the cured ring seal adjacent the tissue surrounding the opening comprises:
positioning the cured ring seal within the opening such that that an outer surface of the cured ring seal is adjacent the tissue surrounding the opening.

### Claim 22 (depends on 15)

The method of claim 15, further comprising:
self-adhering the cured ring seal to the tissue surrounding the opening.

### Claim 23 (depends on 15)

The method of claim 15, further comprising:
delivering one or more therapeutic substances to the fluidically-sealed body chamber via the cured ring seal.

### Claim 24

(canceled)

### Claim 25

(canceled)

### Claim 26 (depends on 15)

The method of claim 15, wherein fluidically-sealed body chamber is a bone chamber of the recipient.

### Claim 27 (depends on 15)

The method of claim 15 wherein fluidically-sealed body chamber is a cochlea of the recipient, and wherein positioning the cured ring seal adjacent to tissue surrounding the opening comprises:
positioning the cured ring seal adjacent at least one of a round window of the cochlea, an oval window of the cochlea, or a surgically-formed cochleostomy.

### Claim 28

(canceled)

### Claim 29

(canceled)

### Claim 30

(canceled)

### Claim 31

(canceled)

### Claim 32

An apparatus, comprising:
a cured polyvinyl alcohol (PVA) ring comprising a body defining a central aperture,
wherein the cured PVA ring is configured to be disposed around an implantable component adjacent a surface of an opening in a human body, and wherein the cured PVA ring is configured to expand after implantation to fluidically-seal a space between the implantable component and the surface of the opening.

### Claim 33 (depends on 32)

The apparatus of claim 32, wherein the body of the cured PVA ring has a thin-film configuration.

### Claim 34

(canceled)

### Claim 35

(canceled)

### Claim 36

(canceled)

### Claim 37

(canceled)

### Claim 38 (depends on 32)

The apparatus of claim 32, wherein the body of the cured PVA ring is configured to self-adhere to tissue surrounding the opening.

### Claim 39

(canceled)

### Claim 40 (depends on 32)

The apparatus of claim 32, wherein the cured PVA ring further comprises at least one longitudinal projection that circumferentially surrounds the aperture and extends in a distal direction.

### Claim 41

(canceled)

### Claim 42 (depends on 32)

The apparatus of claim 32, wherein the body of the cured PVA ring comprises at least one of a chamfered edge, a beveled edge, or a rounded edge at a transition between a proximal surface of the body and an outer surface of the body, or at least one of a chamfered edge, a beveled edge, or a rounded edge at a transition between a distal surface of the body and an outer surface of the body.

### Claim 43

(canceled)

### Claim 44

(canceled)

### Claim 45 (depends on 32)

The apparatus of claim 32, wherein the body of the cured PVA ring further comprises a distal surface with a curved inner edge.

### Claim 46 (depends on 32)

The apparatus of claim 32, and wherein the body of the cured PVA ring is configured to, after implantation and exposure to aqueous media, absorb the aqueous media and swell.

### Claim 47 (depends on 46)

The apparatus of claim 46, wherein the body of the cured PVA ring has a wettability such that absorption of the aqueous media causes the cured PVA ring to develop adhesive properties.

### Claim 48 (depends on 32)

The apparatus of claim 32, wherein the body of the cured PVA is loaded with one or more therapeutic substances.

### Claim 49

(canceled)
